» Authors » Hisham Mehanna

Hisham Mehanna

Explore the profile of Hisham Mehanna including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 160
Citations 3396
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hillier B, Waterboer T, Brooks J, Nankivell P, Agarwal R, Abou-Foul A, et al.
J Infect . 2025 Feb; 90(3):106438. PMID: 39922388
Objectives: Human papillomavirus (HPV) mediated oropharyngeal cancer (OPC) incidence has increased dramatically. Accurate oral HPV prevalence data are essential for assessing population epidemiology, vaccination and screening programmes. As oral rinse...
2.
Alemany L, Felsher M, Giuliano A, Waterboer T, Mirghani H, Mehanna H, et al.
EClinicalMedicine . 2025 Feb; 79:103018. PMID: 39896062
Background: HPV-related oropharyngeal squamous cell carcinoma (OPSCC) is increasing in incidence, yet there are few well-designed oral HPV epidemiology studies in general populations. This study assessed oral HPV prevalence and...
3.
Croft J, Ainsworth G, Corrigan N, Gordon K, Perry A, Twiddy M, et al.
BMJ Open . 2025 Jan; 15(1):e092422. PMID: 39890139
Introduction: Postsurgical hypoparathyroidism (PoSH) is an iatrogenic condition that occurs as a complication of several different procedures with thyroid surgery being the most common. PoSH has significant short- and long-term...
4.
Williamson A, Nankivell P, Abou-Foul A, Ahmed M, Mehanna H
Head Neck . 2025 Jan; PMID: 39781667
Background: The aim of this clinical survey was to assess variations in head and neck squamous cell carcinoma from an unknown primary (HNSCCUP) diagnostic practices across international centers. Methods: Clinical...
5.
Kenny-Jones M, Nankivell P, Mehanna H, Ozakinci G
Curr Oncol . 2024 Dec; 31(12):7586-7602. PMID: 39727682
Cancer care is evolving, and digital resources are being introduced to support cancer patients throughout the cancer journey. Logistical concerns, such as health literacy and the emotional experience of cancer,...
6.
Abou-Foul A, Dretzke J, Albon E, Kristunas C, Moore D, Karwath A, et al.
Front Oncol . 2024 Dec; 14:1478385. PMID: 39711957
Background: The limitations of the traditional TNM system have spurred interest in multivariable models for personalized prognostication in laryngeal and hypopharyngeal cancers (LSCC/HPSCC). However, the performance of these models depends...
7.
Dretzke J, Abou-Foul A, Albon E, Hillier B, Scandrett K, Price M, et al.
BMJ Open . 2024 Dec; 14(12):e090393. PMID: 39638589
Objectives: This systematic review aims to evaluate externally validated models for individualised prediction of recurrence or survival in adults treated with curative intent for oropharyngeal cancer. Design: Systematic review. Setting:...
8.
Bresadola L, Weber D, Ritzel C, Lower M, Bukur V, Akilli-Ozturk O, et al.
BJC Rep . 2024 Nov; 2(1):62. PMID: 39516649
Background: Head and neck squamous cell carcinomas (HNSCCs) are heterogeneous in terms of origin and aetiology. In addition, there is uncertainty about the genetic evolution from initial diagnosis to recurrence...
9.
Singer S, Hammerlid E, Tomaszewska I, Amdal C, Herlofson B, Santos M, et al.
Eur J Cancer . 2024 Oct; 212:115062. PMID: 39405647
Introduction: Minimal important change estimates (MIC) are useful for interpreting results of clinical research with quality of life (QoL) as an endpoint. For the European Organisation for Research and Treatment...
10.
Mehanna H, Sidhu P, Madani G, Woolley R, Boelaert K, Nankivell P, et al.
Radiology . 2024 Oct; 313(1):e240705. PMID: 39404634
Background There is variable evidence and no randomized trials on the benefit of US elastography-guided fine-needle aspiration cytology (FNAC) over conventional US-guided FNAC alone for thyroid nodules. Purpose To compare...